VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
AMN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
AMNAMN Healthcare Services, Inc.
$35.86$1.4B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksAMNCash Flow

AMN Healthcare Services, Inc. (AMN) Cash Flow Statement

26Y historyFree accessUpdated daily

Operating cash flow swung from +$562.5M in Q1 2026 to -$189.9M in Q2 2026, driven by a $624.5M reversal in working capital, while FCF margin collapsed from 40.3% to -29.5%.

Income StatementBalance SheetCash FlowRatios

AMN Cash Flow Statement

Annual statement

AMN Cash Flow Statement

AMN Healthcare Services, Inc. (AMN) cash flow statement — 26-year operating, investing & financing cash flows

AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00
Cash from Operations470.76M269.46M320.42M372.17M653.73M305.36M256.83M224.86M226.99M115.26M131.85M57.05M27.68M58.64M60.51M19.31M8.09M98.73M63.69M79.64M54.54M44.09M39.04M65.14M56.85M1.68M-1.59M
Operating CF Margin %-9.87%10.74%9.82%12.47%7.66%10.73%10.12%10.63%5.8%6.93%3.9%2.67%5.8%6.34%2.18%1.17%12.99%5.23%6.84%5.04%6.25%6.21%9.12%7.33%0.32%-0.69%
Operating CF Growth %102.9%-15.9%-13.9%-43.07%114.09%18.9%14.21%-0.94%96.94%-12.58%131.1%106.13%-52.8%-3.1%213.34%138.74%-91.81%55.01%-20.02%46.02%23.7%12.94%-40.08%14.59%3286.12%205.86%-
Net Income104.92M-95.7M-146.98M210.68M444.05M327.39M70.67M113.99M141.74M132.56M105.84M81.89M33.22M32.93M15.95M-26.27M-51.99M-122.18M34.36M36.53M35.09M22.23M17.35M37.79M52.36M-4.39M-5.2M
Depreciation & Amortization146.62M156.6M173.78M160.93M137.11M103.7M94.19M58.52M41.24M32.28M29.62M20.95M15.99M13.54M14.15M16.42M15.08M13.81M14.44M11.67M10.32M6.18M5.84M4.82M3.84M7.71M3.3M
Stock-Based Compensation32.21M30.68M23.32M18.02M30.07M25.22M20.46M16.24M10.81M10.24M11.4M10.28M7.16M6.13M6.22M7.13M8.28M8.71M9.32M8.39M6.8M142K16.1K874K31.88M31.88M0
Deferred Taxes11.37M-19.55M-51.07M-12.93M-24.61M-16.29M-21.63M913K-667K5.61M-9.42M12.68M11.78M3.03M6.95M-1.79M-10.71M-51.72M-3.37M1.14M18.08M19.02M4.09M6.04M7.29M-8.65M-9.73M
Other Non-Cash Items-31.2M96.39M235.46M45.6M67.68M8.84M26.01M16.22M2.25M12.85M11.12M1.58M7.14M1.84M19.51M47.67M57.98M185.6M1.76M2.13M-2.74M4.48M2.44M1.6M-27.58M14.28M27.02M
Working Capital Changes206.84M101.03M85.91M-50.13M-558K-143.49M67.13M18.98M31.61M-78.27M-16.7M-70.33M-47.61M1.16M-2.27M-23.84M-10.56M64.51M7.18M19.77M-13.01M-7.96M9.32M14.02M-10.94M-39.16M-16.98M
Change in Receivables24.92M74.75M219.44M224.85M20.04M-585.27M-8.61M5.71M-10.58M-10.64M-57.16M-98.02M-52.13M-8.45M1.39M-29.02M-15.3M88.73M10.41M5.53M-40.6M-474K0-30.15M-39.48M-39.48M0
Change in Inventory00000-256.12M-5.56M-1.93M14.56M-32.63M-3.34M-7.34M-4M4.33M-12.29M5.6M1.16M0-6.91M8.57M23.83M-106.36M0-36.48M-111.42M-118.81M0
Change in Payables31.17M-20.57M000256.12M5.56M1.93M17.15M-7.86M17.7M29.61M6.13M4.34M2.83M3.66M8.94M01.94M1.72M1.18M-1.2M03.66M2.65M2.65M0
Cash from Investing31.23M4.3M-79.94M-412.49M-170.71M-107.4M-538.17M-291.82M-279.34M-33.45M-257.36M-116.83M-28.23M-47.9M2.96M-1.98M-6.85M-29.25M-48.25M-14.63M-45.68M-115.33M-5.06M-14.01M1.45M-33.78M-94.14M
Capital Expenditures-32.14M-35.63M-80.89M-103.69M-75.83M-53.66M-39.1M-36.46M-36.39M-26.53M-21.96M-27.01M-19.13M-9.05M-5.47M-4.65M-4.17M-3.79M-8.79M-9.15M-9.71M-3.82M-5.06M-13.01M-4.33M-4.5M-2.36M
CapEx % of Revenue0.94%1.3%2.71%2.74%1.45%1.35%1.63%1.64%1.7%1.33%1.15%1.85%1.85%0.89%0.57%0.52%0.6%0.5%0.72%0.79%0.9%0.54%0.8%1.82%0.56%0.87%1.02%
Acquisitions-3.03M65.28M0-292.1M-69.5M-41.26M-476.43M-247.91M-217.36M-1.5M-218.34M-85.07M-14.47M-39.5M00-3.23M0-30.95M-5.48M-35.96M-111.51M0-9.53M-9.53M-12.97M-91.79M
Investments---------------------------
Other Investing64.69M22K-6.76M-26.6M-26.61M-8.99M-7.66M-13.29M-10.67M-8.62M-5.91M-3M10.38M647K8.43M2.67M553K-25.46M-8.5M0000-1M15.31M-19.09M8K
Cash from Financing-183.96M-295.89M-259.45M10.73M-591.87M-34.9M211.49M136.6M37.51M-77.19M126.29M56.2M-2.1M-783K-61.68M-15.3M-26.45M-53.81M-22.33M-50.92M-23.54M86.52M-34.75M-86.47M-33.82M47.21M95.77M
Debt Issued (Net)-170M-285M-250M459.7M0-21.88M240.54M180M120M-44.06M149.68M57M2.23M-681K-53.73M-12.5M-21.86M-53.65M2.04M-37.92M-21.81M89.11M-36.42M137.37M-662K-128.87M45.18M
Equity Issued (Net)-5.04M-2.09M-8.47M-424.74M-576.77M-2.69M-6.93M-18.7M-67.01M-20.16M-13.26M000530K000-28.45M-16.29M-10.58M2.32M1.93M-219.21M-33.06M177.34M52M
Dividends Paid000000000000000000000000000
Share Repurchases-5.04M-2.09M-8.47M-424.74M-576.77M-2.69M-6.93M-18.7M-67.01M-20.16M-13.26M-11.91M-4.45M-2.67M-1.07M000-28.45M-18.51M-37.53M0-110K-219.26M-35.16M00
Other Financing-8.92M-8.8M-9.45M-24.23M-15.1M-10.33M-22.13M-24.7M-15.48M-12.97M-10.13M-796K-4.33M262K-8.48M-2.8M-4.59M-156K4.07M3.29M8.86M-4.9M-258K-4.63M-101K-1.26M-1.41M
Net Change in Cash323.59M-22.13M-18.97M-29.6M-108.84M162.72M-69.97M69.64M-14.57M4.53M1.05M-3.5M-2.51M9.9M1.72M2.08M-25.17M15.74M-7.18M14.07M-14.69M15.2M-779K-35.45M24.48M15.11M43K
Free Cash Flow439.13M233.83M239.53M266.78M572.81M251.69M217.72M188.4M190.61M88.73M109.89M30.04M8.54M49.59M55.04M14.66M3.92M94.94M54.9M70.48M44.82M40.27M33.98M52.13M52.52M-2.82M-3.94M
FCF Margin %12.79%8.56%8.03%7.04%10.92%6.32%9.1%8.48%8.92%4.46%5.78%2.05%0.82%4.9%5.77%1.65%0.57%12.5%4.51%6.06%4.14%5.71%5.4%7.3%6.77%-0.54%-1.71%
FCF Growth %71.88%-2.38%-10.21%-53.43%127.58%15.6%15.56%-1.16%114.81%-19.26%265.79%251.63%-82.77%-9.9%275.34%273.99%-95.87%72.94%-22.11%57.25%11.3%18.53%-34.83%-0.75%1963.91%28.55%-
FCF per Share11.056.076.276.7812.775.244.573.963.921.802.230.620.181.041.180.320.112.911.622.021.301.251.081.311.12-0.09-0.18
FCF Conversion (FCF/Net Income)4.19x-2.82x-2.18x1.77x1.47x0.93x3.63x1.97x1.60x0.87x1.25x0.70x0.83x1.78x3.53x-0.74x-0.16x-0.81x1.85x2.18x1.55x1.98x2.25x1.72x1.09x-0.38x0.31x
Interest Paid29.32M45.11M61.03M48.1M37.52M38.09M22.65M23.73M21.28M17.94M8.06M-5.81M4.6M7.41M13.7M19.67M16.43M7.39M9.6M00000000
Taxes Paid41.46M7.85M28.15M78.26M213.81M106.38M46.26M37.75M30.59M73.75M73.37M-33.13M17.88M18.86M1.86M388K84K5.61M32.95M00000000

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Working capital volatility and earnings quality

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Cash Conversion Disconnect Deepens

In Q2 2026, AMN reported net income of $21.2M but operating cash flow of -$189.9M, an OCF/NI ratio of -8.98, indicating a severe cash conversion breakdown.

The negative operating cash flow despite positive net income suggests that working capital outflows, particularly a $215.1M working capital swing, overwhelmed earnings. This may indicate aggressive revenue recognition or timing issues in collections, warranting scrutiny of the quality of earnings. The prior quarter's OCF/NI of 9.05 highlights extreme quarter-to-quarter volatility, suggesting that cash generation is not reliably tracking profitability.

FCF Swing Highlights Instability

Free cash flow swung from $555.2M in Q1 2026 to -$198.5M in Q2 2026, with FCF margin collapsing from 40.3% to -29.5%, per reported figures.

The dramatic reversal in FCF is driven by the working capital swing, not capex, which remained stable around $9M. This suggests that AMN's cash flow is highly sensitive to the timing of receivables and payables, likely reflecting hospital clients' payment behavior. The negative FCF in Q2 2026 may indicate that the company is funding growth or absorbing delayed collections, but the sustainability of such swings is questionable.

Working Capital Volatility Drives Cash Flow

Working capital changes swung from +$409.4M in Q1 2026 to -$215.1M in Q2 2026, a $624.5M reversal, per the cash flow statement.

This extreme volatility suggests that AMN's cash conversion cycle is highly unstable, possibly due to large contract timing or changes in hospital payment behavior. The positive working capital in Q1 may have been a one-time collection of receivables, while Q2's negative swing could indicate a build-up in receivables or a drawdown in payables. Investors should monitor DSO trends, as this pattern may signal deteriorating collection efficiency or aggressive revenue recognition.

Capex Discipline Amidst Revenue Decline

Capital expenditures have been consistently reduced from $27.3M in Q2 2024 to $9.0M in Q2 2026, with capex/revenue falling from 3.7% to 1.3%.

The significant reduction in capex suggests management is prioritizing cash preservation over growth investments, which may be appropriate given the revenue contraction. However, this could also indicate underinvestment in technology and infrastructure, potentially undermining the company's long-term competitive position. The low capital intensity relative to revenue implies that the business model is asset-light, but the sustainability of this approach depends on whether the technology segment requires more investment.

Cumulative Earnings vs Cash Reality

Over the last ten quarters, cumulative net income is -$139.1M while cumulative operating cash flow is $902.5M, a divergence of over $1 billion.

The large cumulative gap between net income and operating cash flow suggests that non-cash charges, such as impairments and depreciation, are significant, but also that working capital has been a major source of cash. This may indicate that the company has been liquidating working capital to support cash flow, which is not sustainable. The negative cumulative net income underscores persistent profitability challenges, while the positive cash flow may be masking underlying operational weakness.

What the Cash Flow Statement Obscures

Stock-based compensation of $9.8M in Q2 2026 is a non-cash expense that inflates operating cash flow relative to net income, but the $215.1M working capital swing is the primary distortion.

The cash flow statement highlights the working capital swings, but it does not reveal the underlying drivers, such as changes in DSO or payment terms. The negative net margin of -3.5% despite positive operating cash flow in most quarters suggests that cash flow is being supported by working capital liquidation, not core profitability. Investors should be cautious about interpreting operating cash flow as a sign of health, as it may be masking the deterioration in earnings quality.

AMN — Frequently Asked Questions

Quick answers to the most common questions about buying AMN stock.

How much cash does AMN Healthcare Services, Inc. (AMN) generate from operations?

AMN Healthcare Services, Inc. (AMN) generated $269.5M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is AMN Healthcare Services, Inc.'s free cash flow?

AMN Healthcare Services, Inc. (AMN) generated $233.8M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is AMN Healthcare Services, Inc.'s capital expenditure (CapEx)?

AMN Healthcare Services, Inc. (AMN) spent $35.6M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does AMN Healthcare Services, Inc. distribute cash to shareholders?

In 2025, AMN Healthcare Services, Inc. (AMN) spent $2.1M on share repurchases. This shows the company's commitment to returning capital to its equity investors.